Search

everythinglearnresearchcommunity

for

Search:↓

Hair, skin, and nails supplement use nearly doubled from 2011 to 2020, with higher usage among young adults, females, and certain ethnic groups.

High levels of cortisol in hair are linked to a greater risk of brain aneurysm rupture.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Finasteride does not increase the risk of depression or suicide.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

25% of women in North Sudan have traction alopecia, linked to family history and hair treatments, highlighting the need for better hair care awareness.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Classical PCOS types A and B are most common and linked to higher health risks.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

ALRV5XR is the most effective hair regrowth treatment at 24 weeks.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Lower testosterone levels increase kidney stone risk in men over 40.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

People with Alopecia areata often have lower Vitamin D levels.

Oral finasteride seems more effective for hair loss in postmenopausal women, but more research is needed.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

Certain medications can cause gum problems, so patients and healthcare providers should be aware and monitor oral health.

COVID-19 vaccines caused mostly mild side effects in Bangladeshi medical students, with fewer issues after more doses.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Swiss experts recommend specific guidelines for diagnosing and treating hidradenitis suppurativa to improve patient care.

Hospitalized COVID-19 survivors have a higher risk of long-term symptoms and need special care.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.